Abstract
nt matter & 2012 012.01.005 hor. Tel.: +44 161 2 . ick.crabb@nice.or Abstract The Diagnostics Assessment Programme (DAP) was set up by NICE in 2009 to evaluate innovative medical diagnostic technologies. It was established together with the Medical Technologies Evaluation Programme (MTEP) to undertake more evaluations of medical technologies. A key mechanism for identifying topics for both the MTEP and DAP is notification from a product sponsor. Diagnostic technologies may be assessed in either the DAP or MTEP depending on the value claim. The MTEP allows the relatively rapid assessment of technologies using methods focussed on clinical effectiveness and cost-consequences analysis. The DAP is designed for more complex assessments of diagnostic technologies and methods include cost-effectiveness analysis. A key development in recent years from the pharmaceutical and diagnostics industries is the growing importance of companion diagnostics. It is anticipated that the evaluation of companion diagnostics will be a growing area for NICE involving both the DAP and Technology Appraisals programmes. & 2012 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Annals of The Royal College of Surgeons of England
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
